TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35320229

Group type: EXPERIMENTAL
Intervention: High-force lumbar traction, hot pack, and lumbar stabilisation exercises (group 1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-force lumbar traction, hot pack, and lumbar stabilisation exercises (group 2)
Number of subjects: 30
Study: 32233905

Group type: EXPERIMENTAL
Intervention: Eating Attitudes Test
Number of subjects: 385
Study: 36567637

Group type: EXPERIMENTAL
Intervention: 1 L polyethylene glycol plus ascorbic acid with 24 mg senna (1L-PEG/AS)
Number of subjects: 344

Group type: COMPARATOR
Intervention: 2 L polyethylene glycol plus ascorbic acid (2L-PEG/A)
Number of subjects: 344
Study: 33675247

Group type: EXPERIMENTAL
Intervention: PsyCovidApp intervention
Number of subjects: 440

Group type: COMPARATOR
Intervention: Control App intervention
Number of subjects: 440
Study: 32731903

Group type: EXPERIMENTAL
Intervention: General anesthesia (no specific dosage or duration mentioned)
Number of subjects: 26
Study: 35216581

Group type: EXPERIMENTAL
Intervention: Veverimer
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 33090189

Group type: EXPERIMENTAL
Intervention: Optical coherence tomography (OCT) measures of the optic nerve head and macula
Number of subjects: 104
Study: 35895770

Group type: EXPERIMENTAL
Intervention: 2 mg/kg CBD in oil (oral)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg CBD in DMSO (IV)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no CBD)
Number of subjects: 8
Study: 34265631

Group type: EXPERIMENTAL
Intervention: N95 facemasks
Number of subjects: 52
Study: 32722729

Group type: EXPERIMENTAL
Intervention: NSI-189 80-mg dose
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: NSI-189 40-mg dose
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: NSI-189 (both doses)
Number of subjects: 220
Study: 36294918

Group type: EXPERIMENTAL
Intervention: Intranasal administration of mometasone furoate twice daily along with olfactory training
Number of subjects: 86

Group type: COMPARATOR
Intervention: Olfactory training only (Control)
Number of subjects: 86
Study: 33852250

Group type: EXPERIMENTAL
Intervention: Carboxytherapy gel mask
Number of subjects: 10

Group type: COMPARATOR
Intervention: Petroleum-based lanolin-containing ointment
Number of subjects: 10
Study: 35236066

Group type: EXPERIMENTAL
Intervention: Total Cryotherapy (TCT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Total Cryotherapy (TCT) + Transcranial Magnet Therapy
Number of subjects: 62
Study: 33259351

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Social Support Group (SSG)
Number of subjects: 112
Study: 32629785

Group type: EXPERIMENTAL
Intervention: Injury-induced Dupuytren's contracture (DC)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Injury-unrelated Dupuytren's contracture (DC)
Number of subjects: 132
Study: 36128988

Group type: EXPERIMENTAL
Intervention: Modular cognitive behavioral therapy (M-CBT)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 216
Study: 33684086

Group type: EXPERIMENTAL
Intervention: KDIGO bundle implementation
Number of subjects: 278

Group type: COMPARATOR
Intervention: Control group (no KDIGO bundle)
Number of subjects: 278
Study: 32868016

Group type: EXPERIMENTAL
Intervention: IN.PACT drug-coated balloon (DCB)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 331
Study: 34264782

Group type: EXPERIMENTAL
Intervention: Eccentric heavy resistance training of the injured region
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control exercises of the back and abdominal muscle
Number of subjects: 30
Study: 33168806

Group type: EXPERIMENTAL
Intervention: Educational attainment (EA)
Number of subjects: 815000

Group type: EXPERIMENTAL
Intervention: Cognitive performance (CP)
Number of subjects: 815000
Study: 34889205

Group type: COMPARATOR
Intervention: Finasteride (placebo-controlled)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum steroid levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IGF1 axis
Number of subjects: 0
Study: 32545534

Group type: COMPARATOR
Intervention: Standard self-regulation program (control group)
Number of subjects: 0
Study: 32816246

Group type: EXPERIMENTAL
Intervention: Brigatinib (oral tyrosine kinase inhibitor)
Number of subjects: 442
Study: 32476558

Group type: EXPERIMENTAL
Intervention: Web-based education and counselling for 6 months (first 3 months education, next 3 months counselling)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 80
Study: 34724257

Group type: COMPARATOR
Intervention: Rasagiline 1 mg/day over 12 months
Number of subjects: 165
Study: 34637478

Group type: EXPERIMENTAL
Intervention: Health education sessions and home support program
Number of subjects: 125

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 125
Study: 32651892

Group type: EXPERIMENTAL
Intervention: AG genotype carriers in women
Number of subjects: 2022

Group type: EXPERIMENTAL
Intervention: GG genotype carriers in men
Number of subjects: 2022

Group type: EXPERIMENTAL
Intervention: Carriers of the rs2175898 G allele
Number of subjects: 2022

Group type: EXPERIMENTAL
Intervention: AG+GG/AG genotype in men
Number of subjects: 2022

Group type: COMPARATOR
Intervention: AG genotype in women and GG genotype in men
Number of subjects: 2022
Study: 35829980

Group type: EXPERIMENTAL
Intervention: Integrated model A based on T2WI and ADC images
Number of subjects: 133
Study: 33675347

Group type: EXPERIMENTAL
Intervention: Antenatal iron supplementation (60 mg elemental iron as ferrous fumarate daily from 13-23 weeks of gestation until 1 month postpartum)
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Antenatal iron supplementation
Number of subjects: 470
Study: 32273169

Group type: EXPERIMENTAL
Intervention: Multimodal ovarian cancer screening using a longitudinal CA125 algorithm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extended follow up in the UKCTOCS trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surveillance of high risk women
Number of subjects: 0
Study: 35792881

Group type: EXPERIMENTAL
Intervention: 10-tablet default
Number of subjects: 6309

Group type: EXPERIMENTAL
Intervention: 5-tablet default
Number of subjects: 6309

Group type: COMPARATOR
Intervention: Control (no change)
Number of subjects: 6309
Study: 34031220

Group type: EXPERIMENTAL
Intervention: Basivertebral nerve (BVN) ablation
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 140
Study: 32259823

Group type: EXPERIMENTAL
Intervention: Nascum®‐Plus (NP)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 18
Study: 35667420

Group type: EXPERIMENTAL
Intervention: Surgery with intrauterine instillation of hyaluronic acid gel
Number of subjects: 343

Group type: COMPARATOR
Intervention: Surgery alone (control group)
Number of subjects: 343
Study: 33789284

Group type: EXPERIMENTAL
Intervention: Bardoxolone methyl
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study: 35748445

Group type: EXPERIMENTAL
Intervention: Sea salt‐lemon essence Closeup natural smile
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Signal Complete 8 Charcoal
Number of subjects: 27

Group type: COMPARATOR
Intervention: Signal Complete 8 Original (control)
Number of subjects: 27
Study: 33557254

Group type: EXPERIMENTAL
Intervention: Dog-assisted therapy based on the Comprehensive Cognitive Activation Program in Dementia for 8 months, with weekly sessions of 45 min
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Dog-assisted therapy
Number of subjects: 334
Study: 32539076

Group type: EXPERIMENTAL
Intervention: rAAVrh74.MHCK7.micro-dystrophin, single dose of 2.0 × 10^14 vg/kg infused through a peripheral limb vein, daily prednisolone 1 mg/kg starting 1 day before gene delivery (30-day taper after infusion)
Number of subjects: 4
Study: 34245777

Group type: EXPERIMENTAL
Intervention: HIIT (4 × 4‐min of high‐intensity work periods at 85%–95% peak heart rate)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: NW (resting HR + 20–40 bpm)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: MICT (resting HR + 20–40 bpm)
Number of subjects: 135

Group type: COMPARATOR
Intervention: All groups (HIIT, NW, MICT)
Number of subjects: 135
Study: 34570596

Group type: EXPERIMENTAL
Intervention: Zoster vaccine live (ZVL)
Number of subjects: 617

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 617
Study: 36382358

Group type: EXPERIMENTAL
Intervention: EDP-514 200 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: EDP-514 400 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: EDP-514 800 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 34338114

Group type: EXPERIMENTAL
Intervention: Resveratrol-based multivitamin supplement
Number of subjects: 101

Group type: COMPARATOR
Intervention: Folic acid
Number of subjects: 101
Study: 34843669

Group type: EXPERIMENTAL
Intervention: Optimised regimen (25 mg/kg loading dose, followed by 15 mg/kg every 12 h or 8 h for 5 ± 1 days)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Standard regimen (no loading dose; 15 mg/kg every 24 h, 12 h, or 8 h for 10 ± 2 days)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Optimised regimen
Number of subjects: 242

Group type: COMPARATOR
Intervention: Standard regimen
Number of subjects: 242
Study: 33593795

Group type: EXPERIMENTAL
Intervention: c-LRTI-VAS (COPD-Lower Respiratory Tract Infection Visual Analogue Score)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: c-LRTI-VAS
Number of subjects: 190
Study: 32349692

Group type: EXPERIMENTAL
Intervention: Online guided self-help Cognitive Behavioral Therapy-Enhanced intervention
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control waiting list condition
Number of subjects: 180
Study: 35354636

Group type: EXPERIMENTAL
Intervention: Family-based intervention comprising self-management of disabilities, economic empowerment, and psychosocial support.
Number of subjects: 630

Group type: COMPARATOR
Intervention: Usual practice and care (control group).
Number of subjects: 630
Study: 32114899

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA for 20 min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham tDCS (2 mA for 30 s)
Number of subjects: 30
Study: 32362229

Group type: EXPERIMENTAL
Intervention: Intensive BP lowering (target SBP <120 mm Hg)
Number of subjects: 8022

Group type: COMPARATOR
Intervention: Standard BP lowering (target SBP <140 mm Hg)
Number of subjects: 8022

Group type: EXPERIMENTAL
Intervention: Intensive BP lowering
Number of subjects: 8022
Study: 35320161

Group type: COMPARATOR
Intervention: Saline (placebo) administered at the same rate as lidocaine
Number of subjects: 90
Study: 34306189

Group type: EXPERIMENTAL
Intervention: Intravenous and/or nebulized neutral electrolyzed saline combined with usual medical care
Number of subjects: 214

Group type: COMPARATOR
Intervention: Usual medical care alone
Number of subjects: 214
Study: 35294397

Group type: EXPERIMENTAL
Intervention: Tesomet (0.5 mg tesofensine/50 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 33032712

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 892

Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 892
Study: 35902780

Group type: EXPERIMENTAL
Intervention: Tasty School model (intervention)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 130
Study: 32168178

Group type: EXPERIMENTAL
Intervention: Total Body (TB) resistance training
Number of subjects: 21

Group type: COMPARATOR
Intervention: Split Routine (SR) resistance training
Number of subjects: 21
Study: 36260302

Group type: EXPERIMENTAL
Intervention: cCDT (alteplase, 0.5 mg/catheter/h for 24 hours) plus heparin
Number of subjects: 94

Group type: COMPARATOR
Intervention: Anticoagulation monotherapy
Number of subjects: 94
Study: 35114778

Group type: COMPARATOR
Intervention: LAA stroke group
Number of subjects: 353

Group type: COMPARATOR
Intervention: cerebral SVD stroke group
Number of subjects: 353
Study: 35774483

Group type: EXPERIMENTAL
Intervention: Real tDCS (1.5 mA, 20 min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 40
Study: 35170457

Group type: EXPERIMENTAL
Intervention: Community sensitization through community meetings, wall paintings, and distribution of pamphlets
Number of subjects: 79
Study: 32861428

Group type: EXPERIMENTAL
Intervention: Oral and parenteral pharmacological agents for spasticity management
Number of subjects: 0
Study: 35432560

Group type: EXPERIMENTAL
Intervention: Jie Yu Wan (JYW) high dose (24 g/day)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Buspirone high dose (30 mg/day)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Jie Yu Wan (JYW) low dose (12 g/day)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Buspirone low dose (15 mg/day)
Number of subjects: 133
Study: 33508955

Group type: EXPERIMENTAL
Intervention: Home training
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Supervised training
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 32847570

Group type: EXPERIMENTAL
Intervention: Moxonidine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 33685418

Group type: EXPERIMENTAL
Intervention: Stress management training (1.5 days + 2 booster sessions of 180 min each at 3 and 6 months)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Waiting control group
Number of subjects: 200
Study: 32894811

Group type: EXPERIMENTAL
Intervention: Covid‐19 diagnosis and its effect on kidney function
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Covid‐19 diagnosis
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Covid‐19 diagnosis in severe pneumonia group
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Laboratory findings in ARDS group
Number of subjects: 96
Study: 33034707

Group type: EXPERIMENTAL
Intervention: 500 mg of olive leaf extract (OLE) for 8 weeks
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 77
Study: 32217429

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (25 mg, 50 mg, 75 mg)
Number of subjects: 1105
Study: 35698072

Group type: EXPERIMENTAL
Intervention: Planned lactation education program (two sessions in the hospital and three 20-minute sessions in health centers)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no lactation education program)
Number of subjects: 80
Study: 33987696

Group type: EXPERIMENTAL
Intervention: Light angle at 60°
Number of subjects: 51

Group type: COMPARATOR
Intervention: Light angle at 30°
Number of subjects: 51

Group type: COMPARATOR
Intervention: Light angle at 0°
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Light angle at 30° and 60°
Number of subjects: 51
Study: 34850180

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma injections
Number of subjects: 26

Group type: COMPARATOR
Intervention: Corticosteroid injections
Number of subjects: 26
Study: 32551876

Group type: EXPERIMENTAL
Intervention: Secure attachment style
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Anxiety-avoidance styles
Number of subjects: 200
Study: 35599775

Group type: EXPERIMENTAL
Intervention: ActiveCBT (30 min of moderate intensity exercise before CBT sessions)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ActiveCBT
Number of subjects: 10

Group type: COMPARATOR
Intervention: CalmCBT (30 min of usual activities before CBT sessions)
Number of subjects: 10
Study: 32441856

Group type: EXPERIMENTAL
Intervention: Recent heart failure hospitalization
Number of subjects: 3988
Study: 33096517

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (sham subcutaneous infiltration)
Number of subjects: 60
Study: 33021598

Group type: EXPERIMENTAL
Intervention: Dried Amniotic Membrane (AM)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Petrolatum gauze (control)
Number of subjects: 35
Study: 36057376

Group type: EXPERIMENTAL
Intervention: Choice architecture intervention to nudge clinicians toward non-opioid treatments for opioid-naïve patients.
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Integration of the prescription drug monitoring program (PDMP) within the EHR.
Number of subjects: 43
Study: 33666270

Group type: EXPERIMENTAL
Intervention: Probiotic supplements (3.2 × 10^9 CFU per day for 12 weeks)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo (empty capsules filled with starch)
Number of subjects: 76
Study: 35675898

Group type: EXPERIMENTAL
Intervention: Compression of the fourth ventricle (CV4) technique
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sacral technique (ST)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham compression of the fourth ventricle (sCV4)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham sacral technique (sST)
Number of subjects: 40
Study: 32452923

Group type: EXPERIMENTAL
Intervention: Intense Pulsed Light (IPL)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (instant warm compresses + MGX)
Number of subjects: 120
Study: 32618395

Group type: EXPERIMENTAL
Intervention: Face-to-face group positive psychotherapy (PPC)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Online group positive psychotherapy (OPPC)
Number of subjects: 269
Study: 35285277

Group type: EXPERIMENTAL
Intervention: VS-6766
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VS-6766 plus defactinib
Number of subjects: 0
Study: 33789572

Group type: EXPERIMENTAL
Intervention: Casual attire
Number of subjects: 632

Group type: COMPARATOR
Intervention: White coat
Number of subjects: 632
Study: 32642839

Group type: COMPARATOR
Intervention: Quadratus lumborum block (QLB)
Number of subjects: 7
Study: 36112778

Group type: EXPERIMENTAL
Intervention: Gimsilumab (anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33962258

Group type: EXPERIMENTAL
Intervention: Sinusoidal Vibration A (20 Hz, 3 mm)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Sinusoidal Vibration B (20 Hz, 5 mm)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (no vibrations)
Number of subjects: 15
Study: 33218878

Group type: EXPERIMENTAL
Intervention: Oral carbohydrate (OCH)-rich drink
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Intravenous dextrose 10% infusion
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control
Number of subjects: 95
Study: 32278771

Group type: EXPERIMENTAL
Intervention: Monthly intravitreal 0.5 mg ranibizumab
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Monthly intravitreal 0.5 mg ranibizumab plus TRP
Number of subjects: 40

Group type: COMPARATOR
Intervention: 3 monthly ranibizumab (loading doses) followed by as-needed (PRN) injections and TRP
Number of subjects: 40
Study: 37353143

Group type: EXPERIMENTAL
Intervention: Ventricular volume (VV) estimation
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: VP shunt insertion
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Gestational age
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Maximum ventricular index and anterior horn width
Number of subjects: 59
Study: 34397332

Group type: EXPERIMENTAL
Intervention: Methylene blue (MB)
Number of subjects: 11
Study: 32769639

Group type: EXPERIMENTAL
Intervention: Interpersonal therapy-based intervention (n=129)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Time-matched control group (n=121)
Number of subjects: 250
Study: 34254567

Group type: EXPERIMENTAL
Intervention: Toxoplasma gondii infection (seroprevalence)
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Anti-T. gondii IgM positivity
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Anti-T. gondii IgG positivity
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: IgG plus IgM positivity
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Residence in rural communities
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Islam religion
Number of subjects: 415
Study: 35078530

Group type: EXPERIMENTAL
Intervention: We Can Quit (WCQ) - a peer‐delivered community‐based stop‐smoking programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced usual care by the Irish Health Service Executive (HSE)
Number of subjects: 0
Study: 32122863

Group type: EXPERIMENTAL
Intervention: Staging acupuncture treatment after stroke
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional acupuncture method
Number of subjects: 30
Study: 34024812

Group type: EXPERIMENTAL
Intervention: Sustained natural apophyseal glide (SNAG)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham SNAG
Number of subjects: 64
Study: 32596297

Group type: EXPERIMENTAL
Intervention: Allergen immunotherapy (AIT) for 3 years
Number of subjects: 36
Study: 35981565

Group type: EXPERIMENTAL
Intervention: Rivipansel
Number of subjects: 345

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 345
Study: 33982388

Group type: EXPERIMENTAL
Intervention: Self-management programme based on an attitude-social influence-self-efficacy model
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 32245197

Group type: EXPERIMENTAL
Intervention: Whey protein supplementation (0.33 g·kg−1·d−1 protein)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (isonitrogenous control, 0.33 g·kg−1·d−1 protein)
Number of subjects: 16
Study: 33744331

Group type: EXPERIMENTAL
Intervention: Fentanyl with Ketamine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dexmedetomidine
Number of subjects: 60
Study: 32912091

Group type: EXPERIMENTAL
Intervention: Chronic Disease Self-Management Program (CDSMP) workshops
Number of subjects: 241
Study: 32698326

Group type: EXPERIMENTAL
Intervention: Filipino version of the Pittsburgh Sleep Quality Index (PSQI)
Number of subjects: 131
Study: 33879535

Group type: EXPERIMENTAL
Intervention: Patterns of covarying grey matter (GM) volumes using spatial independent component analysis (ICA)
Number of subjects: 988

Group type: EXPERIMENTAL
Intervention: ICA measures
Number of subjects: 988
Study: 33285602

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (1.4 mg elemental Zn/kg/d orally for 10 days)
Number of subjects: 180
Study: 32936046

Group type: EXPERIMENTAL
Intervention: Vitamin D levels (25-hydroxyvitamin D) in men
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Vitamin D levels (25-hydroxyvitamin D) in women
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Fatigue measured with ESAS in men
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Fatigue measured with ESAS in women
Number of subjects: 530